KORU Medical Systems, Inc. (KRMD) Fair Value 2026

KRMD · Medical Instruments & Supplies ·

By CirclFi Research Team · Data from SEC EDGAR, FRED & GDELT

Quality Score

6.5 /10

32 fundamental signals · 3 models active

Value Trap Risk

SAFE (8/100)

Quick Summary — As of 2026-08-27, KORU Medical Systems, Inc. (KRMD) trades at $3.20, versus a $1.21 median fair value across its 3 active models — 62.1% below the current price. QOC: 6.5/10. Value Trap Risk: 8/100 (SAFE). 3/13 models active. Within that set, the Bayesian DCF component alone returns $0.32.

Key Facts

Ticker
KRMD
Price
$3.20
Quality Score
6.5/10
Value Trap Risk
8/100
Models Active
3/13
Last Updated
Strength: 3 independent models provide multi-angle coverage
Risk: Majority of models suggest overvaluation

Is KORU Medical Systems, Inc. (KRMD) Undervalued or Overvalued in 2026?

According to CirclFi’s 3-model valuation engine, KORU Medical Systems, Inc. (KRMD) appears overvalued as of : the median of 3 independent fair value estimates is $1.21, 62.1% below the current price of $3.20. Estimates range from $0.32 to $1.32. KRMD scores 6.5/10 on fundamental quality and 8/100 on value-trap risk.

For context, the median US equity CirclFi rates trades at an implied -23.7% versus its own 13-model consensus, across 3,801 rated companies as of 2026-08-27. KRMD’s -62.1% gap is wider than that market norm, and the Medical Instruments & Supplies sector median is -36.1%. Full market index →

This verdict compares price to intrinsic value only — it is not a buy or sell rating. For the decision case (bull vs bear arguments, risk factors, peers), read Should You Buy KORU Medical Systems, Inc. Stock in 2026? →

What Fair Value Does Each Model Give KRMD?

3 Intrinsic Value Models vs. Current Price ($3.20)

Core Models (Unlocked)
Model Fair Value Upside
Intrinsic · High Conviction
 $0.32 -89.9%
Relative · Medium Conviction
 $1.21 -62.1%
Relative · Low Conviction
 $1.32 -58.7%

All Models Active

All 3 models are displayed above.

What Is KRMD's Fair Value Range?

Spread across 3 independent models · $0.32 to $1.32

CirclFi's 3 active models place KORU Medical Systems, Inc. (KRMD) between $0.32 and $1.32 per share, a spread of 82% of the median. The median of that range — $1.21 — is the fair value CirclFi publishes for KRMD, against a current price of $3.20.

Low · Bayesian DCFHigh · FTNN
$0.32median $1.21$1.32
Where the range comes from
Most bearish modelBayesian DCF$0.32
Most bullish modelFTNN Topology$1.32
Model agreement0 bullish · 3 bearishmoderate

A band of this width is typical. The methods agree on direction but weight growth, reinvestment and risk differently, so treat the median as a centre of gravity rather than a precise target.

Every figure above is one model's standalone output on KRMD, not a CirclFi price target. How each model works →

What Is KORU Medical Systems, Inc. (KRMD) Worth in 2026?

According to the CirclFi Deep Alpha Valuation Engine, KORU Medical Systems, Inc.'s intrinsic value is estimated at $1.21. Trading at its current price of $3.20, the valuation engine raises significant caution: 3 of 3 models flag downside risk, projecting a median implied return of -62.1%. Model dispersion is worth noting: FTNN targets $1.32 (-58.7%), versus Bayesian DCF at $0.32 (-89.9%). This +31.2% range highlights the importance of multi-model analysis rather than relying on any single methodology.

What Do the Models Say About KRMD?

3 of 13 models are currently active for KRMD. All 3 active models suggest the stock trades above fair value. Taken together, their median fair value for KRMD is $1.21 — the figure CirclFi publishes as this stock's fair value. One component of that median, the Bayesian DCF, returns $0.32 on its own, implying -89.9% downside from the current price. See which stocks rank higher →

How Does KRMD Rank in Medical Instruments & Supplies?

Among 55 Medical Instruments & Supplies stocks, KRMD ranks #29 by Quality of Company score. CirclFi's QOC score of 6.5/10 evaluates 32 fundamental signals. A score of 6.5 indicates above-average quality.

See all Most Undervalued Medical Instruments & Supplies Stocks →

KORU Medical Systems, Inc. operates in a competitive landscape where fundamental quality metrics are key differentiators for long-term value creation.

Is KRMD a Value Trap?

CirclFi's Value Trap algorithm assigns KRMD a score of 8/100 (SAFE). This indicates minimal risk. Fundamentals are healthy. The score cross-references apparent undervaluation against fundamental deterioration signals. Browse lowest value-trap stocks →

Multi-Model Methodology

3 of 13 models are active for KORU Medical Systems, Inc.. Limited activation may indicate insufficient history. Each model applies a fundamentally different valuation philosophy. See the complete methodology →

According to the CirclFi Deep Alpha Valuation Engine, KORU Medical Systems, Inc. scores 6.5 out of 10 on our 32-signal quality assessment, a solid rating that maintains reasonable quality metrics with some areas for improvement. The QOC score synthesizes profitability margins, revenue growth reliability, debt management, and capital allocation into a single metric designed to separate durable businesses from statistically cheap ones.

The gap between the most bullish and bearish model spans +31.2% — demonstrating why single-model analysis is dangerous. Browse all stocks with 13-model coverage →

Data Sources & Confidence

Every KRMD valuation is built from SEC EDGAR XBRL filings — 700+ standardized financial tags. Macroeconomic context from FRED calibrates discount rates, while GDELT news sentiment feeds into our Sentiment SOTP model. All pipelines run daily. Read the complete data methodology →

Across KRMD's 3 active models, average confidence is 38%. Lower confidence may reflect limited history or high volatility.

CirclFi's output is a research starting point, not a buy/sell signal. All data updates daily. Read the full methodology →

This analysis is produced by the CirclFi Valuation Engine using quantitative models applied to SEC EDGAR filings, public market feeds, and FRED macroeconomic indicators. It is not financial advice.

Read the full investment analysis: Should You Buy KORU Medical Systems, Inc. Stock in 2026? →

Bull case, bear case, risk factors & peer comparison — updated daily

Which Similar Medical Instruments & Supplies Stocks Should You Also Analyze?

10 related Medical Instruments & Supplies stocks with 13-model coverage

AVTRAvantor, Inc.QOC 6.5BAXBaxter International Inc.QOC 6.3ANGOAngioDynamics, Inc.QOC 6.7MMEDMiniMed Group, Inc.QOC 6.3OSUROraSure Technologies, Inc.QOC 6.8BLCOBausch + Lomb CorporationQOC 6.3CUPRCuprina Holdings (Cayman) LimitedQOC 5.6ISRGIntuitive Surgical, Inc.QOC 9.4PDEXPro-Dex, Inc.QOC 7.8RMDResMed Inc.QOC 9.4

Read investment analysis: AVTR · BAX · ANGO · MMED · OSUR · BLCO · CUPR · ISRG · PDEX · RMD

Which Other Stocks Have a Similar Quality Score to KRMD?

7 companies across all industries closest to KRMD’s Quality of Company score of 6.5/10.

TAPMolson Coors Beverage CompanyQOC 6.5VRDNViridian Therapeutics, Inc.QOC 6.5CLNEClean Energy Fuels Corp.QOC 6.5BNRBurning Rock Biotech LimitedQOC 6.5RXSTRxSight, Inc.QOC 6.5MNTKMontauk Renewables, Inc.QOC 6.5NVDANVIDIA CorporationQOC 10.0

Read investment analysis: TAP · VRDN · CLNE · BNR · RXST · MNTK · NVDA

Where Does KRMD Sit in CirclFi's Medical Instruments & Supplies Rankings?

KRMD is ranked against every other Medical Instruments & Supplies stock CirclFi covers in each of these screens.

See all Medical Instruments & Supplies stocks ranked →

What Else Do Investors Ask About KORU Medical Systems, Inc.’s Valuation?

What is KORU Medical Systems, Inc.'s intrinsic value in 2026?

CirclFi puts KORU Medical Systems, Inc. (KRMD)'s intrinsic value at $1.21 — the median of 3 independent model estimates as of 2026-08-27, ranging from $0.32 to $1.32. One component of that median, the Bayesian DCF, runs 10,000 Monte Carlo simulations with jump-diffusion and returns $0.32 on its own. The Quality of Company score is 6.5/10 across 32 fundamental signals. All models use SEC EDGAR filings updated daily. See our methodology page for how each model works.

Is KRMD overvalued or undervalued right now?

At $3.20, 0 of 3 active models suggest KRMD may be undervalued, while 3 indicate potential overvaluation. The median of all 3 fair value estimates is $1.21, 62.1% below the current price of $3.20 — a consensus view that KRMD is overvalued. The assessment depends on which methodology best fits KORU Medical Systems, Inc.'s business model in Medical Instruments & Supplies.

What does a Quality of Company score of 6.5 mean for KRMD?

KORU Medical Systems, Inc.'s QOC of 6.5/10 reflects 32 fundamental signals: profitability margins, revenue growth consistency, balance sheet leverage, free cash flow generation, and capital allocation efficiency. Scores between 5-7 reflect moderate fundamentals with areas for improvement.

How many valuation models does CirclFi run on KRMD?

CirclFi analyzes KRMD with 13 institutional-grade models daily: Bayesian DCF (Monte Carlo + jump-diffusion), EPV (Greenwald zero-growth), EROIC Spread (McKinsey reinvestment), First Chicago (3-scenario), Markov DDM (regime-switching), ML-RIV (machine learning residual income), Dynamic NAV (asset-based), PWERM (option-theoretic), Regime Cross-Sectional (relative), Sentiment SOTP (hybrid), CUCE Ensemble (meta-model), FTNN Topology (neural network), and RCMH-DCF (conditional regime). Currently 3 of 13 are active for this stock. Read the full methodology →

Which valuation models are most bullish and most bearish on KRMD?

Of the 3 models currently active on KRMD, FTNN Topology is the most bullish at $1.32 per share, and Bayesian DCF is the most bearish at $0.32. CirclFi's published fair value for KRMD is the median of that range, $1.21, not either extreme. The gap between the two ends equals 82% of the median — a normal spread for a company of this profile. Browse stocks by value-trap risk →

Is KRMD a value trap in 2026?

KORU Medical Systems, Inc.'s Value Trap score is 8/100 (SAFE). This low score indicates the current valuation is not artificially depressed by fundamental deterioration, suggesting genuine opportunity rather than a trap.

Cite this analysis — “According to CirclFi’s 3-model valuation engine, KORU Medical Systems, Inc. (KRMD) has a median fair value of $1.21 — 62.1% below the current price of $3.20 — as of 2026-08-27.” Source: circlfi.com/stock/KRMD/ · Methodology
Primary sources for this KRMD valuation
  • Financial statements: KORU Medical Systems, Inc. 10-K and 10-Q filings on SEC EDGAR (CIK 0000704440) — 700+ standardized XBRL tags, published by the U.S. Securities and Exchange Commission.
  • Discount-rate inputs: FRED, Federal Reserve Bank of St. Louis — risk-free rates, VIX, yield curve, inflation.
  • News sentiment: The GDELT Project — global media tone, input to the Sentiment SOTP model.
  • Model definitions: CirclFi methodology — the published specification for all 13 models, including the academic sources each one implements.

Market data for KRMD as of ; valuations recomputed .